EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC 4.0

A Novel Transcriptional Slippage Mechanism Rescues Dystrophin Expression from a DMD Frameshift Variant

Hiroya Naruse, Jun Mitsui, Akatsuki Kubota, So Okubo iD, Shuichiro Mitsuchi, Kensho Sumi, Shuichi Tanifuji, Shogo Komaki, Asuka Kitamura, Meiko Maeda iD, Daiki Yashita, Atsushi Sudo und 5 weitere

Annals of Neurology · 2025

DOI: 10.1002/ana.78096 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Annals of Neurology, 2025. Verfasst von Hiroya Naruse und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan. Hauptthemen laut MEDLINE: Dystrophin, Muscular Dystrophy, Duchenne, Frameshift Mutation. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pathogenic DMD variants usually follow the reading‐frame rule: out‐of‐frame changes cause Duchenne muscular dystrophy, whereas in‐frame ones produce Becker muscular dystrophy (BMD). We report a 23‐year‐old man with BMD‐like weakness, calf hypertrophy, elevated creatine kinase, and dilated cardiomyopathy. A novel hemizygous c.2281delG variant converted an A₄GA₅ motif to A₉, predicting a frameshift; however, Western blot showed ~15% full‐length dystrophin. cDNA and polymerse chain reaction (PCR)‐free direct RNA sequencing demonstrated transcriptional slippage, adding 1 adenine (A₁₀) that restores the reading frame and dystrophin. This RNA‐level rescue of an out‐of‐frame DMD variant explains the mild phenotype and highlights the importance of transcript‐level analysis in dystrophinopathies. ANN NEUROL 2025

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DystrophinMuscular Dystrophy, DuchenneFrameshift MutationHumansMaleYoung Adult

Substanzen

DystrophinDMD protein, human

Autor:innen und Institutionen

  • Department of Neurology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Department of Precision Medicine Neurology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Institute of Medical Genomics, International University of Health and Welfare, Chiba, Japan.
  • National Center Hospital, National Center of Neurology and Psychiatry, Tokyo, Japan.

ORCID-Profile: So Okubo, Meiko Maeda, Takashi Matsukawa

Zitieren

APA

Naruse, H., Mitsui, J., Kubota, A., Okubo, S., Mitsuchi, S., Sumi, K., Tanifuji, S., Komaki, S., Kitamura, A., Maeda, M., Yashita, D., Sudo, A., Matsukawa, T., Hamada, M., Satake, W., Tsuji, S., & Toda, T. (2025). A Novel Transcriptional Slippage Mechanism Rescues Dystrophin Expression from a DMD Frameshift Variant. Annals of Neurology. https://doi.org/10.1002/ana.78096

Vancouver

Naruse H, Mitsui J, Kubota A, Okubo S, Mitsuchi S, Sumi K, et al. A Novel Transcriptional Slippage Mechanism Rescues Dystrophin Expression from a DMD Frameshift Variant. Annals of Neurology. 2025. doi:10.1002/ana.78096

BibTeX
@article{Naruse2025,
  author = {Naruse, Hiroya and Mitsui, Jun and Kubota, Akatsuki and Okubo, So and Mitsuchi, Shuichiro and Sumi, Kensho and Tanifuji, Shuichi and Komaki, Shogo and Kitamura, Asuka and Maeda, Meiko and Yashita, Daiki and Sudo, Atsushi and Matsukawa, Takashi and Hamada, Masashi and Satake, Wataru and Tsuji, Shoji and Toda, Tatsushi},
  title = {A Novel Transcriptional Slippage Mechanism Rescues Dystrophin Expression from a DMD Frameshift Variant},
  journal = {Annals of Neurology},
  year = {2025},
  doi = {10.1002/ana.78096}
}
Kostenlos starten →